Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i> -Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic DriverCatherine Emmanuel, Anna DeFazio, Peter Russell et al.|Clinical Cancer Research|2014Cited by 119
Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease PathogenesisCatherine Emmanuel, Anna DeFazio, Natalie Gava et al.|PLoS ONE|2011Cited by 40
<i>BRAF</i> Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF InhibitionTania Moujaber, Anna DeFazio, Dariush Etemadmoghadam et al.|JCO Precision Oncology|2018Cited by 40